Ribonucleic Acid News and Research

RSS

Study finds co-infected individuals carrying two distinct lineages of SARS-CoV-2 in Argentina

Researchers used molecular surveillance to identify cases of co-infection with SARS-CoV-2 variants of concern Delta and Omicron reported in Argentina during December 2021 and January 2022.

17 Mar 2022

Study reports reduced disease severity in Syrian hamsters during re-infection with SARS-CoV-2 Delta variant

Researchers studied the immune responses in Syrian hamsters re-infected with SARS-CoV-2 Delta and B.1 variants three months after the primary infection.

17 Mar 2022

Novel mathematical model could predict the evolutionary trend of SARS-CoV-2

Researchers used a novel mathematical model to simulate SARS-CoV-2 dynamics inside the host.

17 Mar 2022

Researchers develop extraction-free saliva RT-LAMP assay for workplace surveillance of SARS-CoV-2

Researchers developed a saliva-based, extraction-free reverse transcription loop-mediated isothermal amplification workflow for SARS-CoV-2 detection.

17 Mar 2022

Frail and older males more vulnerable to COVID-19 than females

Researchers evaluated the association of biological sex, frailty, and age with the vaccine-elicited immunity against SARS-CoV-2.

17 Mar 2022

Study explores profiles of COVID-19 vaccines across different countries

A new study analyzed the amplitude, time, and adverse events associated with COVID-19 vaccines across different countries.

17 Mar 2022

Wastewater monitoring reveals emergence and spread of SARS-CoV-2 Omicron in Alberta

Researchers utilize variant-specific RT-qPCR assays to monitor wastewater to monitor the prevalence of the Omicron and Delta variants.

16 Mar 2022

Multisystem inflammatory syndrome as a late complication in COVID-19 infected children

Researchers determined the immune signature of the multisystem inflammatory syndrome in children among hospitalized children diagnosed with SARS‐CoV‐2 infection.

16 Mar 2022

Young adults protected by booster COVID-19 vaccine during Omicron dominant period

Researchers estimate the impact of COVID-19 booster doses on infection in a vaccinated population of young adults during Omicron-dominant period.

16 Mar 2022

Placenta found to demonstrate anti-oxidant activity against COVID-19 in full-term pregnancy

Researchers assessed the placental anti-oxidant response in the third trimester of pregnancy against SARS-CoV-2 infections.

16 Mar 2022

Novel targets to inhibit SARS-CoV-2 variants

A new study identified additional targets on SARS-CoV-2 proteins to prevent the emergence of new SARS-CoV-2 variants of concern.

16 Mar 2022

New insight into SARS-CoV-2 nsp14 protein opens door to new drugs

In a recent research paper currently available on bioRxiv* preprint server, scientists from the University of Oxford in the United Kingdom and the University of Auckland in New Zealand identified several structural specificities of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that may serve as viable starting points for the development and optimization of viral inhibitors against coronavirus disease 2019 (COVID-19) and other future threats.

16 Mar 2022

Ribonucleic Acid News and Research

Study finds co-infected individuals carrying two distinct lineages of SARS-CoV-2 in Argentina

Study reports reduced disease severity in Syrian hamsters during re-infection with SARS-CoV-2 Delta variant

Novel mathematical model could predict the evolutionary trend of SARS-CoV-2

Researchers develop extraction-free saliva RT-LAMP assay for workplace surveillance of SARS-CoV-2

Frail and older males more vulnerable to COVID-19 than females

Study explores profiles of COVID-19 vaccines across different countries

Wastewater monitoring reveals emergence and spread of SARS-CoV-2 Omicron in Alberta

Multisystem inflammatory syndrome as a late complication in COVID-19 infected children

Young adults protected by booster COVID-19 vaccine during Omicron dominant period

Placenta found to demonstrate anti-oxidant activity against COVID-19 in full-term pregnancy

Novel targets to inhibit SARS-CoV-2 variants

New insight into SARS-CoV-2 nsp14 protein opens door to new drugs

Within-host mathematical model provides insight into dynamics of SARS-CoV-2 infection

Can cardiac biomarkers determine COVID-19 prognosis?

Good glycemic control in SARS-CoV-2 vaccinated type 2 diabetic patients reduces risk of breakthrough infection

How capable are children to self-swab for SARS-CoV-2?

SARS-CoV-2 infection model generated from human tonsil epithelial organoids

Anti-spike IgG dynamics after 2nd BNT162b2 COVID-19 vaccine dose in Japanese health care workers

Sustainable material-based biosensors for SARS-CoV-2 detection

New Phase 1 clinical trial of mRNA HIV vaccine enrolls first participant

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News